{
    "2019-03-29": [
        [
            {
                "time": "2023-10-01",
                "original_text": "NASH Scorecard So Far This Year: A Look at the Hits & Misses",
                "features": {
                    "keywords": [
                        "NASH",
                        "Scorecard",
                        "Hits",
                        "Misses"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "AZN",
                        "Cancer",
                        "Deal",
                        "ABBV",
                        "NVS",
                        "Drug",
                        "Approvals"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Global Blood Focuses on Developing Lead Candidate Voxelotor",
                "features": {
                    "keywords": [
                        "Global",
                        "Blood",
                        "Developing",
                        "Lead",
                        "Candidate",
                        "Voxelotor"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}